T
TSHA//CIK 0001806310
Taysha Gene Therapies, Inc.
Market Data
$5.58−$0.84 (−13.08%)
TSHA · Last trade
Prev Close
$6.42
Range (28d)
$5.38 – $6.94
Recent Filings
- 8-K541.9 KBTaysha Gene Therapies, Inc.Jun 25, 4:26 PM ET·0001193125-26-282855
- 8-K4.5 MBTaysha Gene Therapies, Inc.Jun 22, 8:14 AM ET·0001193125-26-276738
- 8-K152.7 KBTaysha Gene Therapies, Inc.Jun 2, 4:05 PM ET·0001193125-26-253478
- 10-Q9.7 MBTaysha Gene Therapies, Inc.May 6, 8:30 AM ET·0001193125-26-207666
- 8-K224.6 KBTaysha Gene Therapies, Inc.May 6, 8:11 AM ET·0001193125-26-207633
- 10-K19.9 MBTaysha Gene Therapies, Inc.Mar 19, 8:31 AM ET·0001193125-26-115202
- 8-K225.9 KBTaysha Gene Therapies, Inc.Mar 19, 8:08 AM ET·0001193125-26-115177
- 8-K329.2 KBTaysha Gene Therapies, Inc.Nov 4, 7:12 AM ET·0001193125-25-263543
- 10-Q16.8 MBTaysha Gene Therapies, Inc.Nov 4, 6:54 AM ET·0001193125-25-263506
- 8-K165.4 KBTaysha Gene Therapies, Inc.Oct 16, 4:10 PM ET·0001193125-25-241415
Insiders
10- Alam KamranCHIEF FINANCIAL OFFICER
- Astellas Pharma Inc.10% Owner
- Audentes Therapeutics, Inc.10% Owner
- Donenberg Phillip B.Director
- Long Alison SDirector
- Manning Paul B10% Owner
- Nagendran SukumarDirector, President and Head of R&D
- Nolan Sean P.Director, Chief Executive Officer
- PRASAD SUYASHCMO and Head of R&D
- Reape KathleenDirector
Tickers
Addresses
business
3000 PEGASUS PARK DRIVE SUITE 1430
DALLAS, TX, 75247
mailing
3000 PEGASUS PARK DRIVE SUITE 1430
DALLAS, TX, 75247